Agilent to invest $150m for expansion of Frederick production facility in US

SourcePharmaceutical Business Review
Date Published08/19/2020
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Agilent
Type of work Manufacturing
Reshoring category:Reshoring
Year reshoring announced:2020
Year reshoring implemented or to be implemented:2022
Capital investment ($):150
City reshored to:Frederick
State(s) reshored to:CO
If relevant, work nearshored to:-
Product(s) reshorednucleic acid-based therapeutics/ oligos
Find Reshoring Articles